CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?
Chimeric antigen receptor (CAR) T-cell systemic immunotherapy has revolutionized how clinicians treat several refractory and relapsed hematologic malignancies. Due to its peculiar mechanism of action, CAR T-cell-based therapy has enlarged the spectrum of neurological toxicities. CAR T-cell-associate...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2023-04-01
|
| Sarja: | Frontiers in Neurology |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1144414/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|